Table 1 The data of dynamic observation of 205 MS patients, started GA therapy in 2000
Time | Treated | Discontinued the GA therapy | |||
|---|---|---|---|---|---|
Started | Continues | Clinical failure (including change to SPMS course) | Tolerability and side effects | Others (including pregnancies, deaths, migration, escaping from observation, etc.) | |
Baseline | 205 | ||||
3 years | 155 (76 %) | 37 (18 %) | 8 (4 %) | 5 (2 %) | |
155 | |||||
5 years | 91 (59 %) | 42 (28 %) | 12 (8 %) | 7 (5 %) | |
91 | |||||
10 years | 74 (81 %) | 10 (11 %) | 2 (2 %) | 5 (3 %) | |
74 | |||||
15 years | 69 (93 %) | 1 (1 %) | 1 (%) | 3 (5 %) | |
69 | |||||
Continues 35 | Stopped 34 | ||||